Aclarion, Inc. Common Stock (ACON) is a publicly traded Healthcare sector company. As of July 21, 2026, ACON trades at $2.52 with a market cap of $6.48M and a P/E ratio of -0.28. ACON moved -1.52% today. Year to date, ACON is -41.03%; over the trailing twelve months it is -63.06%. Its 52-week range spans $2.34 to $3,499.51. Analyst consensus is buy with an average price target of $7.50. Rallies surfaces ACON's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for ACON, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $2.52 |
| Market Cap | $6.48M |
| P/E Ratio | -0.28 |
| EPS | $-9.03 |
| Dividend Yield | 0.00% |
| 52-Week High | $3,499.51 |
| 52-Week Low | $2.34 |
| Volume | 39.95K |
| Avg Volume | 0 |
| Revenue (TTM) | $77.88K |
| Net Income | $-8.05M |
| Gross Margin | 19.35% |
1 analysts cover ACON: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $7.50.